OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies
Pascale Fanen, Adeline Wohlhuter‐Haddad, Alexandre Hinzpeter
The International Journal of Biochemistry & Cell Biology (2014) Vol. 52, pp. 94-102
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Variant Interpretation: Functional Assays to the Rescue
Lea M. Starita, Nadav Ahituv, Maitreya J. Dunham, et al.
The American Journal of Human Genetics (2017) Vol. 101, Iss. 3, pp. 315-325
Open Access | Times Cited: 340

ABC Family Transporters
Xiaodong Liu
Advances in experimental medicine and biology (2019), pp. 13-100
Closed Access | Times Cited: 216

SLC Family Transporters
Xiaodong Liu
Advances in experimental medicine and biology (2019), pp. 101-202
Closed Access | Times Cited: 201

Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
Hironori Adachi, Yi Pan, Xueyang He, et al.
Molecular Cell (2023) Vol. 83, Iss. 4, pp. 637-651.e9
Open Access | Times Cited: 44

Characterization and small-molecule stabilization of the multisite tandem binding between 14-3-3 and the R domain of CFTR
Loes M. Stevers, Chan Vinh Lam, S. Leysen, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 9
Open Access | Times Cited: 133

Current Progress in Therapeutic Gene Editing for Monogenic Diseases
V. Prakash, Marc T. Moore, Rafael J. Yáñez‐Muñoz
Molecular Therapy (2016) Vol. 24, Iss. 3, pp. 465-474
Open Access | Times Cited: 121

Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine
Shailendra Dwivedi, Purvi Purohit, Radhieka Misra, et al.
Indian Journal of Clinical Biochemistry (2017) Vol. 32, Iss. 4, pp. 374-398
Open Access | Times Cited: 94

Gel-forming mucin interactome drives mucus viscoelasticity
Bastien Demouveaux, Valérie Gouyer, F. Gottrand, et al.
Advances in Colloid and Interface Science (2017) Vol. 252, pp. 69-82
Closed Access | Times Cited: 91

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Cecilia Velino, Francesca Carella, Alessio Adamiano, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 83

Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO
Michalina Banaszak, Ilona Górna, Dagmara Woźniak, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 573-573
Open Access | Times Cited: 42

Prognostication and Risk Factors for Cystic Fibrosis via Automated Machine Learning
Ahmed M. Alaa, Mihaela van der Schaar
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 73

Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy
Ziying Yan, Zoe A. Stewart, Patrick L. Sinn, et al.
Human Gene Therapy Clinical Development (2015) Vol. 26, Iss. 1, pp. 38-49
Open Access | Times Cited: 69

Suppression of Nonsense Mutations by New Emerging Technologies
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4394-4394
Open Access | Times Cited: 51

Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age
Michal Shteinberg, A. Ben Lulu, D.G. Downey, et al.
Journal of Cystic Fibrosis (2018) Vol. 18, Iss. 4, pp. 525-529
Open Access | Times Cited: 57

Translating the genetics of cystic fibrosis to personalized medicine
Harriet Corvol, Kristin Thompson, Olivier Tabary, et al.
Translational research (2015) Vol. 168, pp. 40-49
Open Access | Times Cited: 55

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
Michele Marangi, Giuseppa Pistritto
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 53

MANAGEMENT OF ENDOCRINE DISEASE: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues
Raquel Barrio
European Journal of Endocrinology (2014) Vol. 172, Iss. 4, pp. R131-R141
Open Access | Times Cited: 45

Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine
Lăcrămioara Ionela Butnariu, Elena Ţarcă, Elena Cojocaru, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5821-5821
Open Access | Times Cited: 30

CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway
Edward J. Sanderlin, Melissa M. Keenan, Martin Mense, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Cystic Fibrosis – a Multiorgan Protein Misfolding Disease
Douglas Fraser‐Pitt, Deborah A. O′Neil
Future Science OA (2015) Vol. 1, Iss. 2
Open Access | Times Cited: 34

N-acetyl cysteine reverts the proinflammatory state induced by cigarette smoke extract in lung Calu-3 cells
Ángel G. Valdivieso, Andrea Dugour, Verónica Sotomayor, et al.
Redox Biology (2018) Vol. 16, pp. 294-302
Open Access | Times Cited: 34

Synthesis and structure–activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis
Emanuela Pesce, Marta Bellotti, Nara Liessi, et al.
European Journal of Medicinal Chemistry (2015) Vol. 99, pp. 14-35
Closed Access | Times Cited: 34

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis
Alessia Finotti, Roberto Gambari
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 3-3
Open Access

Page 1 - Next Page

Scroll to top